Accordingly, following RRM2 knockdown, the IC50 values of cisplatin significantly decreased in T24 and UMUC3 cells (Figure 10H), implying that RRM2 may cause cisplatin resistance in BLCA. Here, RRM2 is linked to bladder transitional cell carcinoma.